Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) May Be an Alternative Preventive Therapy in Children with Cerebral Palsy
Tarih
2015Yazar
YILMAZ, Esra Yamac
Tuna, Elif Bahar
Aytepe, Zeynep
Ozdas, Didem Oner
Üst veri
Tüm öğe kaydını gösterÖzet
Purpose: To evaluate the effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) on the buffering capacity of saliva and plaque pH in individuals with cerebral palsy (CP).
Koleksiyonlar
- Makale [92796]